NCAPH was overexpressed in 12.2% of normal cervical squamous epithelium (10/82), 14.7% of high-grade squamous intraepithelial lesion (HSIL) (5/34) and 40.6% of ICSCC (67/165) (Table 1). This evidence concerns the gene NCAPH and squamous cell intraepithelial neoplasia.